One-glance verdict
$173.13 our estimate vs market $412.62
Wall Street consensus: $445.33 (157.2% higher than our fair-value estimate)
138% above our estimate, beyond the bull case
Fundamentals snapshot
WST · NYQ · Healthcare · Medical Instruments & Supplies
Current price
$412.62
52-week range
$223.83 - $438.27
Market cap
$28.74B
One-glance verdict
Wall Street consensus: $445.33 (157.2% higher than our fair-value estimate)
138% above our estimate, beyond the bull case
Balance sheet
Net cash $159.10M. Interest coverage shows how many times profit covers the interest bill.
What stands out
What this company does
West Pharmaceutical Services makes special packaging and delivery devices for medicines, like stoppers and seals for vials, and components for syringes, which are crucial for safely getting drugs to patients. Their money primarily comes from selling these high-quality components and services to drug companies worldwide. This is important because their products ensure the medicines inside are kept safe and effective, which directly impacts patient health and the success of the drugs developed by their customers.
"How the company got here" "West Pharmaceutical Services, Inc. has a long history, starting in 1923 when Herman O. West founded a small dental supply business. The company's early focus was on creating rubber components for packaging injectable drugs, which was crucial for the safe storage and distribution of medicines like penicillin and insulin. Over the decades, West expanded its expertise from these basic components to become a global leader in sophisticated containment and delivery systems for injectable medicines. A key turning point was the acquisition of The Tech Group in 2005, which broadened its capabilities into contract manufacturing. This strategic growth has positioned West as a vital partner for pharmaceutical companies worldwide, ensuring the quality and reliability of drug packaging and delivery." "What it actually does" "West Pharmaceutical Services designs and manufactures packaging components and delivery systems for injectable drugs and healthcare products. Think of them as the critical pieces that hold and help administer medicines, ensuring they remain safe, stable, and effective from the factory to the patient. Their products are essential for a wide range of medications, including complex biologics and standard pharmaceuticals. West works closely with pharmaceutical and biotechnology companies to develop solutions that meet stringent quality and regulatory standards, playing a vital role in the global pharmaceutical supply chain." "Proprietary Products" "This segment is the larger part of West's business and focuses on high-value components that are critical for sensitive injectable drugs. These include stoppers and seals that keep drugs sterile and stable, as well as syringe and cartridge components that ensure accurate and consistent drug delivery. West also offers advanced drug delivery systems, like self-injection devices, designed for ease of use and patient safety. This segment serves biologic, generic, and pharmaceutical drug companies, providing them with essential packaging that maintains drug integrity and supports efficient administration." "Contract-Manufactured Products" "This segment involves the design, manufacturing, and assembly of more complex devices used in drug delivery, diagnostics, and surgical applications. Essentially, West acts as a manufacturing partner for pharmaceutical, diagnostic, and medical device companies, producing specialized equipment. While this segment contributes to West's overall revenue, the company's economics are more heavily influenced by its higher-margin proprietary products. This part of the business leverages West's manufacturing expertise to create integrated solutions for various healthcare needs." "What management is betting on now" "West Pharmaceutical Services is focused on innovation and providing high-quality, reliable solutions for injectable drug containment and delivery. Management is prioritizing the development of advanced packaging and delivery systems to meet the increasing complexity of new therapies, such as cell and gene therapies. They are investing in technical performance, regulatory reliability, and global supply chain consistency to differentiate themselves from competitors. The company aims to be a trusted partner for drug developers, working alongside them from the initial concept through to patient delivery, ensuring the safety and effectiveness of life-saving medicines."
Price history
Earnings history
Click any quarter to read the call summary and what the numbers say.
Is it cheap or expensive?
Wall Street consensus is the average analyst price target: $445.33 (157.2% higher than our fair-value estimate).
Our most-likely fair value is $173.13 a share — about 58.0% below today's price of $412.62, so the stock currently looks expensive (overvalued).
Is it drowning in debt?
Net cash $159.1M - more cash than debt. Interest coverage 1272.2x.
West Pharmaceutical Services, Inc.'s profit covers its interest bill about 1272.2 times over. which is stronger than every peer shown here and 1 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.
Total debt $305.00M Interest coverage 1,272.20x This is the baseline the peer rows are being compared against.
Total debt $16.81B Interest coverage 4.87x -100% vs WST Carries about 261.2x less debt cushion than WST.
Total debt $8.81B Interest coverage 0.61x -100% vs WST Carries about 2084.4x less debt cushion than WST.
Total debt $1.38B Interest coverage 9.69x -99% vs WST Carries about 131.3x less debt cushion than WST.
Total debt $9.17B Interest coverage 6.78x -99% vs WST Carries about 187.6x less debt cushion than WST.
What you should know
The numbers
Tap any ? icon to learn what it means.
Valuation
Profitability
Health
Growth
Cash flow
Dividend
Metric explainer
Debt comparison
What you should know